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The complement system is a key component of innate immunity comprised of soluble
components that form a proteolytic cascade leading to the generation of effector
molecules involved in cellular clearance. This system is highly activated not only under
general inflammatory conditions such as infections, collagen diseases, nephritis, and
liver diseases, but also in focal ocular diseases. However, little is known about the
role of the complement system in retinal homeostasis during aging. Using young
(6-week-old) and adult (6-month-old) mice in wild type (C57BL/6) and complement
knockout strains (C1q−/−, Mbl a/c−/−, Fb−/−, C3−/−, and C5−/−), we compared
amplitudes of electroretinograms (ERG) and thicknesses of retinal layers in spectral
domain optical coherence tomography between young and adult mice. The ERG
amplitudes in adult mice were significantly decreased (p < 0.001, p < 0.0001) compared
to that of young mice in all complement knockout strains, and there were significant
decreases in the inner nuclear layer (INL) thickness in adult mice compared to youngmice
in all complement knockout strains (p < 0.0001). There were no significant differences
in ERG amplitude or thickness of the INL between young and adult control mice. These
data suggest that the complement system plays an important role in maintaining normal
retinal integrity over time.
Keywords: aging, complement system, retina, ERG, OCT, EM
INTRODUCTION
Retinal degeneration is a common form of neurodegenerative disease and a leading cause
of vision loss worldwide. In the United States alone, about 3.4 million people are estimated
to have vision loss due to retinal degeneration, and its prevalence is predicted to increase
in industrialized countries with aging populations (Wert et al., 2014). Retinal degeneration
contributes to vision loss in many conditions, including age-related macular degeneration, retinal
detachment, and retinitis pigmentosa. There is considerable genotypic and phenotypic variability
Abbreviations: ERG, Electroretinogram; EM, electron microscopy; INL, inner nuclear layer; RD, retinal degeneration;
SD-OCT, spectral domain optical coherence tomography; IPL/GC, inner plexiform layer/ganglion cell layer; ONL, outer
nuclear layer; ONH, optic nerve head.
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with retinal degeneration which complicates the identification
of mechanisms of degeneration and development of potential
therapeutic approaches for this debilitating condition (Wert
et al., 2014). The complement system has recently become
a topic of intense investigation, and is both a key mediator
of developmental neuronal function and homeostasis, and
contributes to a number of retinal disease pathologies (Sweigard
et al., 2014, 2015; Kim et al., 2016). Cumulatively, these seminal
studies suggest that the complement system is vital to normal
retinal physiology.
The complement system is an essential component of the
innate immune system and plays an important role in immune
function and disease pathogenesis. The complement system
is a hub-like surveillance network of the innate immune
system that plays a vital role in the modulation of immune
and inflammatory responses (Walport, 2001a,b; Harboe and
Mollnes, 2008; Ricklin et al., 2010; Yanai et al., 2012). Activation
of the complement system involves the sequential cleavage
FIGURE 1 | Representative examples of ERG a- and b-wave responses in young (6 weeks) and adult (6 months) mice in each experimental group. In C57BL/6 mice,
the amplitudes of a- and b-waves between young and adult mice were almost identical. On the other hand, both amplitudes were impaired in aged C1q−/−, Mbl−/−,
Fb−/−, C3−/−, and C5−/− mice. A scale was shown at the bottom right.
of proteins that resembles the coagulation cascade (Barnum,
2017). There are a number of proteins that comprise the
complement system’s threemain upstream activation pathways—
classical (complement components C1–C4), alternative (Factors
B and D), and lectin (MASP-1 to 3 and MBL)—as well
as the terminal activation pathway (complement components
C5–C9). Additionally, the system is regulated by soluble
(e.g., Factor H, I) and membrane-bound (e.g., CD55, CD59)
complement regulatory proteins (Barnum, 2017). While liver
hepatocytes are the primary source of complement synthesis,
several other tissues and cell types, ranging from macrophages
to endothelial cells to neurons, are capable of complement
synthesis when induced, and may synthesize some components
constitutively under certain circumstances (Barnum, 2017).
Based on both synthesis location and function, it is evident
that the complement system can affect all parts of the body, so
it is an important consideration in various focal and systemic
pathologies.
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The complement system is complex, with numerous
complement effectors and a variety of receptors with different
effects (McGeer et al., 2017). Thus, any dysfunction or defect
in this complex network will likely be of consequence, as
evidenced by the identification of complement involvement
in numerous systemic (McGeer et al., 2017), inflammatory
(Zhuang and Lyga, 2014), and retinal (Zhuang and Lyga, 2014;
McHarg et al., 2015; Xu and Chen, 2016) pathologies. Indeed,
the complement system has recently been implicated in a
variety of pathophysiological processes, including photoreceptor
degeneration, vascular regression, ischemia/reperfusion injury,
sepsis, stroke, autoimmunity, and inflammatory disorders (Guo
et al., 2005; Walsh et al., 2005; Sjoberg et al., 2009; Langer
et al., 2010; Ricklin et al., 2010; Sweigard et al., 2014, 2015).
Unsurprisingly, there is considerable interest in the development
of complement-based therapeutics, with numerous clinical
trials conducted and underway (Melis et al., 2015; Ricklin and
Lambris, 2016).
The complement system is thought to contribute to general
homeostasis by eliminating immune complexes and apoptotic
cells, as well as mediating cross-talk with immune cells for
adaptive immune functions (Ricklin et al., 2010). During synapse
development and plasticity, C1q, the initiating protein of the
classical complement pathway, is believed to play an important
role in synapse elimination (Stevens et al., 2007). Moreover, C1q
protein levels dramatically increase during normal aging in mice
and the human brain (Stephan et al., 2013). In the study of
sleep and circadian rhythms, the plasma level of complement
components C3, C4, C3a, and C5a appear to fluctuate with the
sleep-awake cycle, thereby suggesting that circadian rhythms
can affect the immune regulatory properties of the complement
system (Reis et al., 2011). In retinal detachment models in mice,
deficiencies in key complement components (i.e., Factor b, or
C3) resulted in a decreased number of apoptotic cells compared
to wild type C57BL/6J mice with retinal detachment (Sweigard
et al., 2015). A similar result was observed in endothelial cell
death in a model of ocular ischemia (Sweigard et al., 2014).
Recent studies of mice deficient in key complement receptors
(C3aR−/− and C5aR−/−) have found that a- and b-wave signals
from electroretinograms (ERGs) of these strains were impaired
in mice that were 14 weeks, 6 months, and 12 months old
compared to ERG readings from strain-matched mice that were
6 weeks old (Yu et al., 2012). Additionally, light microscopy in
C3aR−/− and C5aR−/− mice revealed that inner nuclear layer
(INL) and outer nuclear layer (ONL) thickness in 14-month-
old mice were diminished compared to that of 3-month-old
FIGURE 2 | Quantification of ERG amplitudes in a- and b-waves of young (6 weeks) and adult (6 months) mice in each experimental group. In C57BL/6 mice (A,B),
there was no significant difference in the amplitude of a- and b-waves between the young (n = 5) and old (n = 5) mice. By contrast, both amplitudes were significantly
decreased in old compared to in young C1q−/− mice (a-wave: p < 0.001, b-wave: p < 0.0001; young n = 3, adult n = 3), Mbl−/− mice (a-wave: p < 0.0001,
b-wave: p < 0.0001; young n = 6, adult n = 5), Fb−/− mice (a-wave: p < 0.001, b-wave: p < 0.0001; young n = 4, adult n = 8), C3−/− mice (a-wave: p < 0.001,
b-wave: p < 0.0001; young n = 6, adult n = 4), and C5−/− mice (a-wave: p < 0.001, b-wave: p < 0.0001; young n = 3, adult n = 3) (C–L).
Frontiers in Aging Neuroscience | www.frontiersin.org 3 February 2018 | Volume 10 | Article 15
Mukai et al. Complement Loss Reduces Retinal Function
mice. These results suggest that C3aR and C5aR are necessary
in maintaining normal retinal structure and function (Yu et al.,
2012).
The complement system is active in the retina, RPE, and
choroid under endogenous conditions. Immunohistochemistry
has revealed that C1q is expressed in the retinal ganglion cell
(RGC) layer even during the developmental stage (Stevens et al.,
2007). Furthermore, Factor b (Collier et al., 2011), C3 (Anderson
et al., 2010; Collier et al., 2011; Luo et al., 2011), and C5 (Copland
et al., 2010) components have been detected in normal retinas.
In mRNA analysis, a key component of the mannose-binding-
lectin (Mbl) pathway was also identified in normal retinas (Luo
et al., 2011). However, the role of these complement factors play
under normal conditions is unclear. To fill this knowledge gap,
this study focused on the effects of the three main complement
pathways—classical, lectin, and alternative pathways—on retinal
function and morphology during the normal aging process using
complement-pathway deficient mice.
MATERIALS AND METHODS
Animals
The Massachusetts Eye and Ear Animal Care Committees
approved all animal procedures and experiments prior to
beginning, and all animals were treated in accordance with the
guidelines set forth by the Association of Research for Vision and
Ophthalmology.
In this study, C57BL/6 (stock no. 000664) mice were
purchased from Jackson Laboratories (Bar Harbor ME, USA).
C3−/−, C5−/−, Fb−/−, and C1q−/− mice were a gift from
J.D.L. at the University of Pennsylvania. Mbl A/C−/− mice were
a gift from G. Stahl at Brigham and Women’s Hospital. All
complement-deficient strains were in a C57BL/6 background.
Each strain was maintained as a breeding colony in the
Massachusetts Eye and Ear animal facility. Mice of all
complement knockout stains utilized were screened for:
RD1, RD2, RD3, RD6, RD7, RD8, and RD 10 mutations
(TransnetYX R©), and all strains were negative for these retinal
degenerative genes.
Electroretinography (ERG) Recording
Full-field ERGs were recorded simultaneously from both eyes.
Animals were dark-adapted overnight (>12 h). Mice were
weighed and anesthetized with intraperitoneal injections of
a mixture of ketamine (60 mg/kg) and xylazine (9 mg/kg).
Mydriasis was achieved with one drop of 0.5% tropicamide
with 5% phenylephrine. Corneal anesthesia was performed with
a single drop of 0.5% proparacaine hydrochloride ophthalmic
solution (Akorn Inc. Illinois). A warm heating pad was used to
maintain body temperature (37◦C).
FIGURE 3 | Comparison of ERG a- and b-wave amplitudes among experimental mouse strains at 6 weeks (A,B) and 6 months (C,D) of age. The amplitude of a- and
b-waves in complement knockout strains in C1q−/−, Mbl−/−, Fb−/−, and C3−/− mice were lower than those of C57BL/6 mice at each age, except for C5−/− mice
at 6 weeks of age.
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ERGs were recorded using HMS’s ERG LAB system
(OcuScience, Nevada). Stimulus flashes were presented in a
Ganzfeld bowl. Stimulus intensities ranging from −1.5 to 1.0
log cd s/m2 in 0.5-log units steps were used under dark-adapted
conditions. Light stimuli were presented with a 1-min interval
between successive stimuli.
SD-OCT Imaging
Before optical coherence tomography (OCT) imaging was
performed, each animal was anesthetized by intraperitoneal
Avertin injection (125 mg/kg), and the pupils were dilated with a
drop of 0.5% tropicamide with 5% phenylephrine. Two repeated
volumetric images, centered on the optic nerve head, were
acquired in both eyes using spectral-domain OCT (SD-OCT;
Bioptigen, Inc., Davis, NC). All SD-OCT images consisted of
1,000 A-scans and 100-averaged B scans (each B-scan was the
average of three B-scans). These parameters correspond to the
area of approximately 1.4× 1.4mm.
SD-OCT Image Analysis
The RGC layer, inner plexiform layer and ganglion cell complex
(IPL/GC), INL, and ONL were measured using SD-OCT B-scan
cross-sectional images (Supplementary Figure 1A). To evaluate
the cross-sectional thickness (in microns, µm) of each layer,
manual calipers included in the Bioptigen software program
were used. Retinal en-face scans were divided into inferior,
nasal, temporal, and superior quadrants surrounding the central
retinal subfield containing the optic nerve heads. One B-scan
obtained approximately 400µm from the optic nerve head
(ONH) superiorly or inferiorly was selected for measurement
of each retinal layer (Supplementary Figure 1B superior and
inferior). Three B-scans that included the ONH or approximately
140µm from the ONH superiorly and inferiorly were selected
for measurement of each retinal layer in the nasal and temporal
regions of the fundus. In the superior and inferior B-scan images,
three measurement points were selected as follows: the central
measurement point was determined as just superior or inferior
of the ONH, and the other two points were defined at 300µm
nasally or temporally from this central measurement point. To
measure the retinal thickness in the nasal or temporal area,
three points were selected at 300µm nasally or temporally from
the ONH in the three B-scan images. Therefore, a total of 12
points were used to average the thickness of each retinal layer
(Supplementary Figure 1B).
FIGURE 4 | Mean thickness of retinal sub-layers measured by Spectral Domain Optical Coherence Tomography in young (6 weeks) and adult (6 months) mice in each
experimental group. (A) There was no significant thinning in any retinal layer between 6-week-old and 6-month-old C57BL/6 mice. (B–F) Contrastingly, INL thinning
was identified in all complement knockout strains at the age of 6 months. Values and statistical analysis are summarized in Table 1. RNFL, retinal nerve fiber layer;
IPL/GC, inner plexiform layer/ganglion cell; INL, inner nuclear layer; ONL, outer nuclear layer. Bar = 100µm. *p < 0.05, **p < 0.01, ***p < 0.001, †p < 0.0001.
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Light Microscopy and Electron Microscopy
Mouse eyes were enucleated and immersed in half strength
Karnovsky’s fixative (2% formaldehyde + 2.5% glutaraldehyde
in 0.1M sodium cacodylate buffer, pH 7.4; Electron Microscopy
Sciences, Hatfield, Pennsylvania) at room temperature. An
eyecup was created with each eye by dissecting away the
anterior portion from the posterior portion. Eyecup samples were
then placed back into half-strength Karnovsky’s fixative for a
minimum of 24 h under refrigeration. After fixation, samples
were rinsed with 0.1M sodium cacodylate buffer, post-fixed with
2% osmium tetroxide in 0.1M sodium cacodylate buffer for
1.5 h, en bloc stained with 2% aqueous uranyl acetate for 30min,
then dehydrated with graded ethyl alcohol solutions, transitioned
with propylene oxide, and resin infiltrated in tEPON-812 epoxy
resin (Tousimis, Rockville, Maryland) utilizing an automated
EMS Lynx 2 EM tissue processor (Electron Microscopy Sciences,
Hatfield, Pennsylvania). The whole posterior eye cup was
processed and embedded as a single block in transparent epoxy
resin to prevent outer segment detachment during subsequent
processing and sectioning procedures. The mid optic nerve head
plane within the embedded eyecup was targeted for sectioning
through the use of a stereoscope observing all directions of the
transparent embedded block, then scored for sectioning using
the optic nerve as an exterior reference. An initial precision
saw cut was made into the embedded block away from the
mid-level plane then ground down using a frosted slide. The
edges of the eyecup tissue were trimmed using razor blades
for ultramicrotomy. Sections were subsequently generated at 1
micrometer thickness and stained with toluidine blue stain. The
orientation of photoreceptor outer segments was assessed in
addition to the level through optic nerve head. The angle of cut
and orientation in the both the x and y directions where made to
generate a mid-level plane with regions of retinal photoreceptor
outer segments oriented longitudinally prior to thin sectioning
at 80 nanometers thickness for electron microscopy. Ultrathin
sections (70–90 nm) were cut from the epoxy block using a Leica
EM UC7 ultramicrotome (Leica Microsystems, Buffalo Grove,
IL) and a diamond knife, collected onto 2 × 1mm single slot
formvar/carbon coated grids, and were stained with aqueous
25% Uranyl Acetate Replacement stain (Electron Microscopy
Sciences, Hatfield, Pennsylvania) and Sato’s lead citrate using
a modified Hiraoka grid staining system. Grids were imaged
using a FEI Tecnai G2 Spirit transmission electron microscope
(TEM) (FEI, Hillsboro, Oregon) at 80 kV interfaced with anAMT
XR41 digital CCD camera (Advanced Microscopy Techniques,
Woburn, Massachusetts) for digital TIFF file image acquisition.
TEM imaging of all layers of the retina was used to capture
representative regions. When analyzing the number of dense
inclusions in the outer plexiform layer (OPL), 10 images taken at
x11,000 magnification were selected every 50µm from the optic
nerve head in each mouse strain.
Statistical Analysis
All data are expressed as means ± SE. ERG comparisons in
a-wave or b-wave signals were made between 6-week-old and
6-month-old mice using two-way analysis of variance (ANOVA),
and comparisons of retinal thickness were analyzed using a two-
tailed student’s t-test. The Pearson r-test was used to estimate
the correlation between retinal thickness and ERG amplitude.
P < 0.05 were considered statistically significant.
RESULTS
Reduced Retinal Function with Age in
Complement Knockout Mice
Significant decreases in the ERG amplitude of both a-wave and
b-waves were detected in all strains of complement knockout
mice that were 6 months old, compared to that of complement
knockout mice (strain-matched mice) at 6 weeks of age; however,
no such age-related differences were noted in C57BL/6 mice
(Figures 1, 2). The extent of signal loss was more severe in the
classical pathway knockout (C1q−/−) and alternative pathway
knockout (Fb−/−) strains (Figure 3).
Thinning of Retinal Layers with Age in
Complement Knockout Mice
Inner nuclear layer (INL) thickness was significantly decreased in
C1q−/−, Mbl−/−, Fb−/−, C3−/−, and C5−/− mice at 6 months
TABLE 1 | Changes in thickness of different retinal layers in 6-week-old or
6-month-old mice from each experimental strain.
Layer Strain Thickness (SE) µm P-values
6 weeks n 6 months n
ONL
C57BL/6 63.35(0.38) 10 62.53(0.38) 6 0.18
C1q−/− 65.46(0.22) 4 62.25(0.36) 6 <0001
Mbl−/− 64.73(0.51) 7 64.03(0.51) 10 0.34
Fb−/− 65.50(0.48) 5 61.03(0.32) 14 <0.0001
C3−/− 62.45(0.34) 14 58.83(0.46) 8 <0.0001
C5−/− 65.94(0.40) 6 60.76(0.55) 7 <0.0001
INL
C57BL/6 30.38(0.24) 10 30.07(0.27) 6 0.42
C1q−/− 30.90(0.34) 4 26.88(0.22) 6 <0.0001
Mbl−/− 31.34(0.42) 7 27.88(0.34) 10 <0.0001
Fb−/− 31.43(0.48) 5 23.32(0.46) 14 <0.0001
C3−/− 29.03(0.31) 14 22.14(0.46) 8 <0.0001
C5−/− 31.78(0.30) 6 24.68(0.80) 7 <0.0001
IPL/GC
C57BL/6 55.47(0.31) 10 54.22(0.61) 6 0.06
C1q−/− 51.67(0.84) 4 49.39(0.24) 6 <0.05
Mbl−/− 55.22(0.64) 7 54.53(1.17) 10 0.64
Fb−/− 54.25(0.68) 5 52.32(0.41) 14 <0.01
C3−/− 52.32(0.40) 14 50.79(0.57) 8 <0.05
C5−/− 56.93(0.56) 6 54.24(0.34) 7 <0.01
RNFL
C57BL/6 15.93(0.20) 10 15.51(0.26) 6 0.22
C1q−/− 15.75(0.23) 4 15.76(0.15) 6 0.98
Mbl−/− 16.72(0.44) 7 15.83(0.31) 10 0.11
Fb−/− 15.08(0.14) 5 15.15(0.48) 14 0.86
C3−/− 16.91(0.17) 14 14.77(0.16) 8 <0.0001
C5−/− 15.90(0.25) 6 15.54(0.36) 7 0.70
RNFL, Retinal nerve fiber layer; IPL/GC, inner plexiform layer/ganglion cell; INL, inner
nuclear layer; ONL, outer nuclear layer. Significant differences in each layer between young
and old animals for each KO strain were detected and noted in bold.
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of age compared to that in strain-matched mice at 6 weeks of
age; however, no such age-related differences in INL thickness
were found between 6-week-old and 6-month-old C57BL/6 mice
(Figure 4). Specifically, we observed the following reductions
in INL thickness in 6-month-old mice compared to 6-week-old
mice: 23% reduction in C1q−/−, 21% in Mbl−/−, 36% in Fb−/−,
34% in C3−/−, and 23% in C5−/− mice. There were significant
decreases in the thickness of the IPL/GC in C57BL/6, C1q−/−,
Fb−/−, C3−/−, and C5−/− mice; however, only a 1.3–4.7%
reduction was identified (Table 1).
Positive Correlation between the
Amplitude of B-Waves and the Thickness
of the INL and IPL/GC
According to retinal single cell recordings, it is thought that the
ERG is a mass retinal response in which the a-wave is generated
by photoreceptors and the b-wave primarily reflects activation
of bipolar cells. Thus, we analyzed the correlation between a-
wave amplitude and ONL thickness, the correlation between b-
wave amplitude and INL thickness, and the correlation between
b-wave amplitude and IPL/GC thickness. A positive correlation
between the b-wave amplitude and INL thickness (r2 = 0.5263,
p < 0.01), as well as a correlation between b-wave amplitude and
IPL/GC thickness (r2 = 0.7608, p< 0.001), were noted. However,
no significant correlation was identified between the a-wave
amplitude and ONL thickness (Supplementary Figures 2, 3).
Histologic Analysis
Light microscopic and electron microscopic images were
obtained in each mouse strain in order to define the
morphological changes induced in the retina when there was
a deficiency in complement system activity. INL thinning was
observed via electron and lightmicroscopy inC1q−/− andC3−/−
mice that were 6 months of age relative to mice at 6 weeks of age
(Figures 5, 6). In Fb−/−, C5−/−, andMbl−/− mice, there was no
difference between 6-week-old and 6-month-oldmice (Figure 7).
In particular, phagocytized cells were identified in the INL in
the C1q−/− strain (Figure 8). Dense inclusions in the OPL have
previously been identified as the degeneration of the junction
between photoreceptors and bipolar cells (Wang et al., 2016). Our
retinal samples also contained dense inclusions in the OPL in
Mbl−/−, Fb−/−, C3−/−, and C5−/− mice that were 6 months old.
Furthermore, similar dense inclusions were identified in strain-
matched mice that were 6 weeks old (Figure 9, Supplementary
Figure 4, Table 2).
DISCUSSION
Retinal functional abnormalities were detected in C1q−/−,
Mbl−/−, Fb−/−, C3−/−, and C5−/− mice at 6 months of
age compared to in mice at 6 weeks of age under normal,
disease-free conditions. This functional deterioration seemed
to correlate with thinning of the inner retina in these strains.
FIGURE 5 | Representative light microscopic and electron microscopic images comparing the retinal layer thickness of C57BL/6 (A–D) and C1q−/− (E–H) mice at 6
weeks (A,C,E,G) and 6 months (B,D,F,H) of age. (A–D) No thinning in any retinal layer were observed between 6-week-old and 6-month-old C57BL/6 mice. (E–H) In
C1q−/− mice at 6 months of age, the thickness of inner nuclear layer seemed to be thinner than that in C1q−/− mice at 6 weeks of age. Bar = 100µm, (F)
Bar = 10µm (H).
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FIGURE 6 | Representative light microscopic (A,B) and electron microscopic
images (C,D) comparing the retinal layer thickness of C3−/− mice at 6 weeks
(A,C) and 6 months of age (B,D). (A–D) The thickness of the inner nuclear
layer in C3−/− mice at 6 months of age (B,D) appears thinner than that in
C3−/− mice at 6 weeks of age (A,C). (A,B) Bar = 100µm. (C,D)
Bar = 10µm.
Additionally, dense inclusions in the OPL were observed via
electron microscopy inMbl−/−, Fb−/−, C3−/−, and C5−/− mice
at 6 months of age. These structural changes in the OPL may
potentially contribute to retinal functional abnormalities, at least
in some complement knockout mice.
In C57BL/6 mice, a mild decrease in a-wave and b-wave
amplitudes was observed in 6-month-old mice compared to in
6-week-old mice; however, the changes were not significant in
this study, indicating that retinal function is preserved from 6
weeks to 6 months in C57BL/6 mice. A previous study detected
significant reductions in a-wave and b-wave amplitudes in 12-
month-old mice, but such reductions were limited in 6-month-
old mice, as compared to 2-month-old mice in the C57BL/6
strain (Li et al., 2001). In another study, authors compared
ERGs from 1-, 4-, and 17-month-old mice, showing significantly
decreased ERG amplitudes in 17-month-old mice compared to
in 1-month-old mice; however, no major differences in ERG
amplitude were detected at least in b-waves between 1-month-old
and 4-month-old mice in same strain (Gresh et al., 2003). These
trends are quite similar to those found in our study.
Decreased amplitudes of both a- and b-waves at 6 months
of age were identified not only in alternative pathway knockout
mice (Fb−/−, C3−/−, and C5−/−), but also in classical (C1q−/−)
as well as mannose-binding-lectin pathway (Mbl−/−) knockout
mice. A previous study in 2012 explored how deficiencies in
alternative pathway components such as C3, C3aR, and C5aR
impacted ERG amplitude in mice (Yu et al., 2012). The authors
identified decreased b-wave amplitudes in C3−/− mice at 12
months of age, as well as decreased a- and b-wave amplitudes
in C3aR−/− and C3aR−/−C5aR−/− mice at 14 weeks, 6 months,
and 12 months of age. In addition, thinning of the INL and
ONL was observed by 14 months of age in C3aR-deficient
mouse strains, as analyzed by retinal histological sections (Yu
et al., 2012). These results seem to support our ERG and
OCT data in alternative pathway-deficient mice (Fb−/−, C3−/−,
and C5−/−).
In this study, we discovered that INL thickness in SD-OCT
was significantly decreased in C1q−/−, Mbl−/−, Fb−/−, C3−/−,
and C5−/− mice at 6 months of age, compared to strain-
matched mice, at 6 weeks of age and that this significantly
correlated with b-wave amplitude. In addition, light microscopy
revealed thinning of the INL in C3−/− and C1q−/− mice in
our study. Specifically, we found that thinning in the INL
inner region was more severe than that of the INL outer
region. We therefore postulate that thinning of inner retinal
layer at 6 months of age may be a key contributor to the
deteriorating retinal function observed in these strains. However,
there were some discrepancies in the results of INL thickness
between SD-OCT and light microscopic finding among KO
lines (Figures 4–7, Table 1). Thinning of the INL observed
by SD-OCT in C3−/− and C1q−/− corresponded to thinning
observed by light microscopic analysis, although there were
some discrepancies in results of INL thickness between SD-OCT
and light microscopic findings in other strains. We regarded
thickness in OCT (Figure 4) as more accurate than thickness in
HE or EM (Figures 5–7), due to the possibility that fixation can
modify the thickness of tissues.
The mechanism for neuronal loss in the INL and ONL
in complement knockout strains, remains unclear. Yu et al.
demonstrated that decreased PKCα staining in the INL correlated
with a reduction in the number of Calbundin D28 positive cells,
and found swelling of the outer segment in aged C3aR−/− and
C3−/− mice in comparison to wild type mice (Yu et al., 2012).
Hoh and colleagues revealed that C3−/− mice had significant
photoreceptor loss and thickening of the Bruch’s membrane as
well as reduced amplitudes in photopic and scotopic responses
in 12-month-old mice, as compared to C57BL/6 mice of the
same age (Hoh Kam et al., 2013). These results suggested
that deficiency of complement components might cause
impairment of signaling function in the inner and outer retinal
layers.
Hoh therefore concluded that inhibition of C3 for treatment
of age-related macular degeneration (AMD) patients might be
deleterious (Hoh Kam et al., 2013). Our ERG findings in C3−/−
mice are in accordance with this study, and strengthen the
possibility that lack of C3 in the retina might contribute to
reduced retinal function over time.
Interestingly, we detected dense inclusions in the OPL via
electron microscopy, which may correspond to the degeneration
of synapses between photoreceptors and bipolar cells (Somogyi
et al., 1977; Linder et al., 1987; Wang et al., 2016), in
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FIGURE 7 | Representative comparison of retinal layer thickness between 6-week-old and 6-month-old Fb−/− (A,B), C5−/− (C,D), and Mbl−/− (E,F) mice. (A–F)
There was no apparent difference in retinal thickness of each layer between mice at 6 weeks of age and those at 6 months of age. (A–F) Bar = 100µm.
complement pathway-deficient (Fb−/−, Mbl−/−, C3−/−, and
C5−/−) mice at 6 months of age. Dense inclusions in the
OPL have been reported previously in microglia-depleted
retinas, with diminished scotopic and photopic responses
due to the destruction of pre-synaptic termini in the OPL
(Wang et al., 2016). These structural changes in the OPL and
electrophysiological changes in b-wave amplitude in microglia-
depleted retinas were similar to our results in normal aging eyes
(Wang et al., 2016). Based on our findings, we hypothesize that
the complement system may maintain retinal integrity under
normal homeostatic conditions. Nevertheless, it is still unclear
why complement depletion may lead to degeneration in the
retina. Dense inclusions were observed in OPL, but their number
was limited (Figure 9, Table 2, Supplementary Figure 4). We
evaluated the number of dense inclusions around the disc area
(and not centrally) as we sought to evaluate the number of dense
inclusions at the same position in all of our complement-deficient
mice. Thus, this could be why the number of dense inclusions was
limited.
When analyzing morphological changes in INL and IPL by
electron microscopy, we focused on morphological changes in
amacrine cells, bipolar cells and horizontal cells. We recognized
the star-like shape of nuclei in amacrine cells as an index.
The Kolmer’s organelle is highly important in order to identify
horizontal cells (Hogan et al., 1971; Richard et al., 2001).
However, there were no obvious changes in these cells in both
young and old complement-deficient strains. Next, we focused
on synaptic ribbons between photoreceptors and bipolar cells,
and compared the number of synaptic ribbons between young
and old mice in complement-deficient strains. Still, there were
no changes in the number of synapse ribbons in all complement-
deficient strains (Supplementary Figure 5). In addition, although
we tried to identify bipolar cells synapses by focusing on the
numerous number of synaptic vesicles in axons of bipolar cells, it
was difficult to identify and compare them among complement-
deficient strains in a quantitative analysis. Moreover, we did not
observe any distinct morphological changes inMüller cells in any
of our complement-deficient strains. In C1q strains, we identified
microglial cells at the inner surface of INL, which appeared to
include phagocytosed cells. From the aspect of the location of
these phagocytosing cells, it is possible that microglial cells had
engulfed bipolar or amacrine cells in at least the C1q strain
(Figure 8).
Of note, our study has shown the functional (Figure 2) and
morphological changes (Figure 7D, Supplementary Figures 6, 7)
in C5−/− mice at 6 months of age. In addition, there appeared
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FIGURE 8 | Phagocytized microglial cells in the inner nuclear layer of C1q−/− mice at 6 months of age. (A–D, white arrows) (A) A microglial cell phagocytizing dead
cells, with dense particles observed in the microglial cell body at the border between the inner nuclear layer and inner plexiform layer (magnification: x1,400). (B) High
magnification image of (A) (magnification: x9,300). (C,D) Microglial cells containing dense particles were detected in other parts of the inner nuclear layer. (C: x13,000,
D: x9,300). (A) Bar = 10µm, (B) Bar = 2µm, (C) Bar = 500 nm, (D) Bar = 2µm.
to be swelling and folding of the outer segment in C5−/− mice
at 6 months of age (Figure 7D, Supplementary Figures 6, 7). By
contrast, previous studies did not show significant reductions
in ERG amplitude and retinal thickness in C5aR−/− mice with
increasing age (Yu et al., 2012). We suspect this may be due to C5
signaling being transmitted through two receptors (Ward, 2009,
2010; Bosmann et al., 2013; Li et al., 2013), such as C5aR1 and
C5L2, which is suggestive that severe dysfunction only in the
absence of both receptors.
Recently, evidence has been accumulating regarding the
association between genetic alterations in complement factor
H (CFH) with the development of age-related macular
degeneration (AMD) in clinical studies. CFH has also been
a topic of intense investigation in basic research (Anderson
et al., 2010; Kondo et al., 2011). Photoreceptor loss and
decreased amplitude in ERG scotopic responses were observed
in 12-month-old CFH knockout mice (Cfh−/−) (Ding et al.,
2015). Additionally, the study noted an apparent decrease in
INL thickness. Outer retinal degeneration resembling retinal
changes seen in AMD was observed in 10-month-old mice
lacking CD46, which is thought to regulate the aggregation of
C3b and C4 (Lyzogubov et al., 2016). Basal laminar deposits were
observed in Fb−/− mice at the age of 6 months in our study
(Supplementary Figure 8). These results suggest that a lack of
alternative pathway components or an imbalanced complement
system could result in retinal degeneration in younger animals,
even under normal conditions. Although a deficiency in CFH or
CD46 could potentially enhance alternative pathway activity and
cause retinal degeneration observed with AMD, it is also possible
that the lack of a fully functional complement system could
equally contribute to alteration of normal retinal homeostasis in
the context of aging.
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FIGURE 9 | Assessment of dense inclusions in the outer plexiform layer (OPL) (A,B, white arrows). Dense inclusions in the OPL have been reported previously in
microglia-depleted retinas, and were due the destruction of pre-synaptic termini in the OPL (Wang et al., 2016). The presence of dense inclusions was identified in
alternative complement pathway deficient mice and corresponded to the border between the tip of photoreceptors and neighboring bipolar cells. (A) Fb−/− mice at 6
weeks of age. Bar = 500 nm. (B) Fb−/− mice at 6 months of age. Bar = 500 nm.
TABLE 2 | The number of dense inclusions in each mouse strain at 6-weeks or
6-months of age.
Strains Age
Young (6 weeks) Old (6 months)
C57BL/6J 0 0
Fb−/− 3 5
C3−/− 16 9
C5−/− 5 11
C1q−/− 0 0
Mbl−/− 2 3
To the best of our knowledge, this is the first study to
suggest that, in addition to C3, C3aR, and C5aR(Yu et al.,
2012), Factor b, C5, C1q, and Mbl A/C of the complement
system are involved in the maintenance of retinal integrity under
normal aging conditions. Further studies are needed to detail the
association between the complement system and other immune
components endogenous conditions, which would enhance our
understanding of the mechanisms of age-related retinal diseases.
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